340B PATIENTS Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsors
- 22
- Latest action
- Jul 22, 2025
What it does
The 340B PATIENTS Act of 2025 would clarify and strengthen the 340B drug discount program by requiring drug manufacturers to offer discounted prices to covered entities regardless of how or where the drugs are dispensed, including through contract pharmacies. It prohibits manufacturers from imposing conditions—such as delivery restrictions, data submission requirements, or other limitations—that would limit covered entities’ ability to access or use discounted drugs, especially for specialty medications. The bill also establishes civil monetary penalties of up to $2 million per day for manufacturers who intentionally violate these provisions, with enforcement mechanisms to be developed by…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.